Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0085L |
Entecavir
BMS200475,SQ34676,恩替卡韦 |
HBV | Microbiology/Virology |
Entecavir (SQ34676) 是一种选择性 HBV 抑制剂,在 HepG2细胞中的 EC50值为3.75 nM。 | |||
T0085 |
Entecavir monohydrate
SQ 34676,BMS-200475,Entecavir hydrate,恩替卡韦 (1水合物),恩替卡韦一水合物 |
HBV | Microbiology/Virology |
Entecavir monohydrate (BMS-200475) 是一种选择性HBV 抑制剂,在HepG2细胞中的EC50值为3.75 nM。 | |||
T70092 |
ent-Entecavir
|
||
ent-Entecavir is an enantiomeric impurity of the antiviral drug Entecavir. Entecavir is an oral antiviral drug used in the treatment of hepatitis B virus (HBV) infection. Entecavir is a reverse transcriptase inhibitor. It prevents the hepatitis B virus from multiplying and reduces the amount of virus in the body. More specifically, it is a deoxyguanosine analogue belonging to a class of carbocyclic nucleosides, that inhibits reverse transcription, DNA replication and transcription in the viral r... | |||
T65556 |
Entecavir-9
|
||
Entecavir-9 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T65556,CAS号为 142217-81-0。 | |||
T63848 | TLR8 agonist 4 | ||
TLR8 agonist 4 能够有效的抑制野生型和耐药(拉米夫定和恩替卡韦)HBV 菌株,他们的IC50值分别为 0.15 和 0.10 μM。 |